AUTOLOGOUS TRANSPLANT IN ELDERLY PATIENTS WITH R/R AGGRESSIVE LYMPHOMA SELECTED BY SIMPLIFIED CGA: THE RECANZ PROSPECTIVE PHASE 2 STUDY BY THE FONDAZIONE ITALIANA LINFOMI.

MLA

Tucci, A., et al. “Autologous Transplant in Elderly Patients with R/R Aggressive Lymphoma Selected by Simplified Cga: The Recanz Prospective Phase 2 Study by the Fondazione Italiana Linfomi.” Hematological Oncology, vol. 39, June 2021, p. 1. EBSCOhost, https://doi.org/10.1002/hon.99_2880.

APA

Tucci, A., Musuraca, G., Cavallo, F., Zilioli, V. R., Zanni, M., Pelliccia, S., Mannina, D., Michieli, M., Vallisa, D., Tani, M., Merli, F., Re, F., Marcheselli, L., Campostrini, G., Pagani, C., Grimaldi, D., Liardo, E. V., Re, A., Cox, M. C., & Rossi, G. (2021). Autologous Transplant in Elderly Patients with R/R Aggressive Lymphoma Selected by Simplified Cga: The Recanz Prospective Phase 2 Study by the Fondazione Italiana Linfomi. Hematological Oncology, 39, 1. https://doi.org/10.1002/hon.99_2880

Chicago

Tucci, A, G Musuraca, F Cavallo, V. R Zilioli, M Zanni, S Pelliccia, D Mannina, et al. 2021. “Autologous Transplant in Elderly Patients with R/R Aggressive Lymphoma Selected by Simplified Cga: The Recanz Prospective Phase 2 Study by the Fondazione Italiana Linfomi.” Hematological Oncology 39 (June): 1. doi:10.1002/hon.99_2880.